Biohaven (BHVN) Other Operating Expenses (2022 - 2025)
Biohaven's (BHVN) quarterly Other Operating Expenses came in at $109.9 million in Q4 2025, down 35.08% quarter-over-quarter from $169.4 million in Q2 2025.
Biohaven (BHVN) Other Operating Expenses (2022 - 2025) Analysis & Trends
Biohaven has disclosed Other Operating Expenses across 2 years of filings, most recently posting $109.9 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109.95 Mn |
| Jun 30, 2025 | 169.37 Mn |
| Dec 31, 2022 | 132.80 Mn |